The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 116.50
Bid: 116.50
Ask: 118.00
Change: 0.00 (0.00%)
Spread: 1.50 (1.288%)
Open: 117.00
High: 117.50
Low: 116.50
Prev. Close: 116.50
RECI Live PriceLast checked at -
Real Estate Credit Investments is an Investment Trust

To provide attractive and stable returns, primarily through quarterly dividends, by exposure to a diversified portfolio of real estate credit investments, predominantly comprising real estate loans and bonds, focusing in UK and Western Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Real Estate Credit Investments (RECI): 7%+ yield from well-secured property debt portfolio

28 Aug 2019 07:30

Hardman & Co Research Hardman & Co Research: Real Estate Credit Investments (RECI): 7%+ yield from well-secured property debt portfolio 28-Aug-2019 / 07:30 GMT/BST


Hardman & Co Research: 7%+ yield from well-secured property debt portfolio

RECI pays investors a high dividend yield (7.3%), covered by predictable income streams generated by an increasingly diversified portfolio of real-estate-backed debt. Its credit record has been exemplary. In this report, we detail the procedures that have delivered this performance, in addition to the benefits from the security taken. Much of the superior revenue yield is generated from service and structuring skills - among the many synergies obtained from having Cheyne Capital (Cheyne) as the manager. Corporate governance appears robust, with a strong board. RECI is exposed to the credit cycle, some of its loan assets may prove illiquid, and the (modest) gearing is low-cost but short-term.

Please click on the link below for the full report:

https://www.hardmanandco.com/research/corporate-research/7-yield-from-well-secured-property-debt-portfolio/

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co35 New Broad StreetLondonEC2M 1NH

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Mark Thomas Mike Foster+44 20 7194 7622

 

mt@hardmanandco.com

mf@hardmanandco.com

 

 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

864067 28-Aug-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
11th Aug 20152:57 pmRNSResult of AGM
4th Aug 20157:00 amRNSFact Sheet Announcement
7th Jul 20157:00 amRNSFact Sheet Announcement
3rd Jul 20157:00 amRNSCirc re. AGM of the Company
2nd Jul 201510:59 amRNSDirectorate Change
16th Jun 201512:00 pmRNSDirector Declaration
12th Jun 20157:00 amRNSMarket Announcement - Chairman rotation
11th Jun 20157:00 amRNSDividend Declaration
11th Jun 20157:00 amRNSAnnual Financial Report
11th Jun 20157:00 amRNSFinal Results
4th Jun 20157:00 amRNSFact Sheet Announcement
1st Jun 20154:16 pmRNSDirectorate Change
19th May 20157:00 amRNSDividend Declaration - Preference Dividend
8th May 201511:28 amRNSNotice of Results
7th May 201512:00 pmRNSFact Sheet Announcement
22nd Apr 20154:22 pmRNSDirectorate Change - Chairman Appointment
8th Apr 20153:09 pmRNSFact Sheet Announcement
10th Mar 20157:02 amRNSFact Sheet Announcement
11th Feb 20157:00 amRNSDividend Declaration - Ordinary Dividend
11th Feb 20157:00 amRNSDividend Declaration - Preference Dividend
4th Feb 20157:00 amRNSFact Sheet Announcement
9th Jan 20157:00 amRNSFact Sheet Announcement
18th Dec 20143:01 pmRNSDirector Declaration
8th Dec 20147:00 amRNSFact Sheet Announcement
5th Dec 20144:15 pmRNSDirector/PDMR Shareholding
28th Nov 20148:45 amRNSPreference Dividend Declaration - Replacement
28th Nov 20148:45 amRNSOrdinary Dividend Declaration - Replacement
28th Nov 20147:00 amRNSDividend Declaration - Ordinary Dividend
28th Nov 20147:00 amRNSDividend Declaration - Preference Dividend
28th Nov 20147:00 amRNSCondensed Interim Financial Report
28th Nov 20147:00 amRNSHalf Year Results
24th Nov 20142:10 pmRNSReturn of Capital to Cell Shareholders
18th Nov 20147:00 amRNSNotice of Results
10th Nov 20147:00 amRNSFact Sheet Announcement
8th Oct 20147:00 amRNSFact Sheet Announcement
7th Oct 201411:26 amRNSMarket Announcement for ERII LN
18th Sep 20142:56 pmRNSTR-1: Notification of Major Interest in Shares
8th Sep 20147:00 amRNSFact Sheet Announcement
14th Aug 20147:00 amRNSDividend Declaration - Preference Dividend
14th Aug 20147:00 amRNSDividend Declaration - Ordinary Dividend
14th Aug 20147:00 amRNSInterim Management Statement
13th Aug 201410:50 amRNSResult of AGM
8th Aug 20147:00 amRNSFact Sheet Announcement
1st Aug 20147:00 amRNSDisclosure of Total Voting Rights
24th Jul 201412:00 pmRNSCircular relating to AGM of the Company
16th Jul 20146:19 pmRNSDirector Declaration
9th Jul 20147:00 amRNSReturn Of Capital To Cell Shareholders
8th Jul 20147:00 amRNSFact Sheet Announcement
18th Jun 20147:00 amRNSPublication of Supplementary Prospectus
12th Jun 20144:58 pmRNSMarket Announcement for ERII LN (the Cell shares)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.